DOR BioPharma, Inc. Announces Release of Advisory Committee Briefing Documents by FDA

MIAMI, FL -- (MARKET WIRE) -- May 07, 2007 -- DOR BioPharma, Inc. (OTCBB: DORB) (“DOR” or “the Company”) announced today that DOR’s briefing document as well as the briefing document of the FDA have been posted by the FDA on the FDA’s website at http://www.fda.gov/ohrms/dockets/ac/07/briefing/2007-4301b1-00-index.htm.